Stay updated on Pembrolizumab & Radiation for Lymphoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab & Radiation for Lymphoma Clinical Trial page.

Latest updates to the Pembrolizumab & Radiation for Lymphoma Clinical Trial page
- ChecktodayChange DetectedThe page now shows Revision: v3.5.4, replacing the prior Revision: v3.5.3. This indicates a small software version update with no announced changes to content or user-facing features.SummaryDifference0.1%

- Check7 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page’s footer revision/version indicator was updated from v3.5.2 to v3.5.3, reflecting a change in the site’s release version rather than any study content.SummaryDifference0.1%

- Check29 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check58 days agoChange DetectedThe page's revision tag was updated to v3.5.0, and the previous v3.4.3 tag was removed.SummaryDifference0.1%

- Check65 days agoChange DetectedThe page shows a revision update from v3.4.2 to v3.4.3. This is a minor version increment with no visible changes to the study details on the page.SummaryDifference0.1%

- Check93 days agoChange DetectedAdded Revision: v3.4.2; removed the prior Notice about government funding lapse and operating-status updates (Revision: v3.4.1) to reflect the latest site update; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Pembrolizumab & Radiation for Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Radiation for Lymphoma Clinical Trial page.